comparemela.com

Latest Breaking News On - Hedge funds weigh in on elevance health - Page 3 : comparemela.com

Elevance Health (NYSE:ELV) Releases FY 2024 Earnings Guidance

Elevance Health (NYSE:ELV – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 37.100- for the period, compared to the consensus estimate of 37.050. The company issued revenue guidance of -. Analyst Ratings Changes Several research analysts have commented on the stock. Morgan Stanley […]

Elevance Health (NYSE:ELV) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Elevance Health (NYSE:ELV – Get Free Report) released its earnings results on Wednesday. The company reported $5.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.02, MarketWatch Earnings reports. Elevance Health had a return on equity of 20.71% and a net margin of 3.61%. The firm had revenue of […]

Elevance Health s (ELV) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research report report published on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $547.00 target price on the stock. Several other research analysts have also commented on the stock. TD Cowen lifted their price objective on shares of […]

Brokers Issue Forecasts for Elevance Health, Inc s FY2023 Earnings (NYSE:ELV)

Elevance Health, Inc. (NYSE:ELV – Free Report) – Stock analysts at Zacks Research boosted their FY2023 earnings estimates for shares of Elevance Health in a report released on Thursday, October 26th. Zacks Research analyst K. Dey now forecasts that the company will post earnings of $33.01 per share for the year, up from their previous […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.